Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 196198, 10 pages
http://dx.doi.org/10.1155/2014/196198
Research Article

Crude Extracts from Lycium barbarum Suppress SREBP-1c Expression and Prevent Diet-Induced Fatty Liver through AMPK Activation

1Biochemistry and Molecular Biology, Ningxia Medical University, Yinchuan 750004, China
2Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan 750004, China

Received 27 March 2014; Revised 13 May 2014; Accepted 20 May 2014; Published 10 June 2014

Academic Editor: Koichiro Wada

Copyright © 2014 Wang Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-A. Kim, Y. Wei, and J. R. Sowers, “Role of mitochondrial dysfunction in insulin resistance,” Circulation Research, vol. 102, no. 4, pp. 401–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-Q. Chen, T. R. Brown, and J. Russo, “Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors,” Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1793, no. 7, pp. 1128–1143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Fabbrini, S. Sullivan, and S. Klein, “Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications,” Hepatology, vol. 51, no. 2, pp. 679–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Nagle, E. L. Klett, and R. A. Coleman, “Hepatic triacylglycerol accumulation and insulin resistance,” Journal of Lipid Research, vol. 50, pp. S74–S79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. J. Raubenheimer, M. J. Nyirenda, and B. R. Walker, “A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet,” Diabetes, vol. 55, no. 7, pp. 2015–2020, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Anderson and J. Borlak, “Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis,” Pharmacological Reviews, vol. 60, no. 3, pp. 311–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. W. Asterholm and P. E. Scherer, “Enhanced metabolic flexibility associated with elevated adiponectin levels,” The American Journal of Pathology, vol. 176, no. 3, pp. 1364–1376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Qureshi and G. A. Abrams, “Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 13, no. 26, pp. 3540–3553, 2007. View at Google Scholar · View at Scopus
  9. M. S. Strable and J. M. Ntambi, “Genetic control of de novo lipogenesis: role in diet-induced obesity,” Critical Reviews in Biochemistry and Molecular Biology, vol. 45, no. 3, pp. 199–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Li, S. Xu, M. M. Mihaylova et al., “AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice,” Cell Metabolism, vol. 13, no. 4, pp. 376–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Luo, Y. Cai, J. Yan, M. Sun, and H. Corke, “Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum,” Life Sciences, vol. 76, no. 2, pp. 137–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Amagase, B. Sun, and C. Borek, “Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults,” Nutrition Research, vol. 29, no. 1, pp. 19–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. L. Lin, C. C. Wang, S. C. Chang, B. S. Inbaraj, and B. H. Chen, “Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus,” International Journal of Biological Macromolecules, vol. 45, no. 2, pp. 146–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. E. Kleiner, E. M. Brunt, M. Van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Benhamed, P.-D. Denechaud, M. Lemoine et al., “The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans,” Journal of Clinical Investigation, vol. 122, no. 6, pp. 2176–2194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-S. Choi, M.-K. Lee, U. J. Jung et al., “Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet,” Molecular Nutrition and Food Research, vol. 53, no. 6, pp. 751–759, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Briand, Q. Thiéblemont, E. Muzotte, and T. Sulpice, “High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivomacrophage-to-feces reverse cholesterol transport in hamsters,” Journal of Nutrition, vol. 142, no. 4, pp. 704–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Matsuzaka and H. Shimano, “Molecular mechanisms involved in hepatic steatosis and insulin resistance,” Journal of Diabetes Investigation, vol. 2, no. 3, pp. 170–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Ferramosca and V. Zara, “Modulation of hepatic steatosis by dietary fatty acids,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1746–1755, 2014. View at Google Scholar
  20. C. Postic and J. Girard, “Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice,” Journal of Clinical Investigation, vol. 118, no. 3, pp. 829–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. M. Anstee and R. D. Goldin, “Mouse models in non-alcoholic fatty liver disease and steatohepatitis research,” International Journal of Experimental Pathology, vol. 87, no. 1, pp. 1–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M.-Y. Park and S. T. Mun, “Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice,” Nutrition Research and Practice, vol. 7, no. 4, pp. 294–301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Zhou, Y. Zhai, Y. Mu et al., “A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway,” Journal of Biological Chemistry, vol. 281, no. 21, pp. 15013–15020, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. K. Stoeckman and H. C. Towle, “The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression,” Journal of Biological Chemistry, vol. 277, no. 30, pp. 27029–27035, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Postic and J. Girard, “The role of the lipogenic pathway in the development of hepatic steatosis,” Diabetes and Metabolism, vol. 34, no. 6, pp. 643–648, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Du, J. Xue, H.-B. Wang, Y. Zhang, and M.-L. Xie, “Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression,” European Journal of Pharmacology, vol. 666, no. 1–3, pp. 183–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Zhang, X. Chen, R.-M. Zhu et al., “Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice,” Toxicology Letters, vol. 212, no. 3, pp. 229–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kohjima, N. Higuchi, M. Kato et al., “SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease,” International Journal of Molecular Medicine, vol. 21, no. 4, pp. 507–511, 2008. View at Google Scholar · View at Scopus
  29. F. Yap, L. Craddock, and J. Yang, “Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription,” International Journal of Biological Sciences, vol. 7, no. 5, pp. 645–650, 2011. View at Google Scholar · View at Scopus
  30. K.-G. Park, A.-K. Min, E. H. Koh et al., “Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways,” Hepatology, vol. 48, no. 5, pp. 1477–1486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E.-J. Jung, S.-W. Kwon, B.-H. Jung, S.-H. Oh, and B.-H. Lee, “Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver,” Journal of Lipid Research, vol. 52, no. 9, pp. 1617–1625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Vankoningsloo, M. Piens, C. Lecocq et al., “Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid β-oxidation and glucose,” Journal of Lipid Research, vol. 46, no. 6, pp. 1133–1149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Santosa and M. D. Jensen, “Adipocyte fatty acid storage factors enhance subcutaneous fat storage in postmenopausal women,” Diabetes, vol. 62, no. 3, pp. 775–782, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Yanagisawa, E. Koike, T. T. Win-Shwe, M. Yamamoto, and H. Takano, “Impaired lipid and glucose homeostasis in hexabromocyclododecane-exposed mice fed a high-fat diet,” Environmental Health Perspectives, vol. 122, no. 3, pp. 277–283, 2014. View at Google Scholar
  35. J. D. Horton, I. Shimomura, S. Ikemoto, Y. Bashmakov, and R. E. Hammer, “Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver,” Journal of Biological Chemistry, vol. 278, no. 38, pp. 36652–36660, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Suqimoto, H. Nakajima, K. Kodo et al., “Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice,” Nutrition and Metabolism, vol. 11, no. 1, article 14, 2014. View at Google Scholar
  37. S.-W. Qian, Y. Tang, X. Li et al., “BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. E798–E807, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Auffret, S. Viengchareun, N. Carré et al., “Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high-fat-dietinduced obesity,” The FASEB Journal, vol. 26, no. 9, pp. 3728–3737, 2012. View at Publisher · View at Google Scholar · View at Scopus